10x Genomics Inc. (TXG)
Market Closed
17 Jul, 20:00
$
43. 74
-0.74
-1.6637%
$
5.42B Market Cap
- P/E Ratio
- Div Yield
2.57M Volume
-2.12 Eps
$ 44.48
Previous Close 
Want to track TXG and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
10x Genomics Inc. (TXG) Statistics
Valuation metrics
Market Cap 5.42B
Enterprise value 5.14B
Trailing P/E (ttm) -257.29
Forward P/E 118.4
PEG ratio -1.01
Price/Sales (ttm) 8.69
Price/Book (mrq) 6.89
Enterprise Value/Revenue 8.05
Enterprise Value/EBITDA 55.14
Overview
Shares outstanding 128.99M
Float 115.09M
Shares short 16.25M
% Held by insiders 0.02%
% Held by institutions 1.1%
Average volume (10 days) 3.42M
Average volume (90 days) 3.01M
Price summary
52-Week low 11.16
52-Week high 46.32
Beta 2.05
50-Day moving average 37.9
200-Day moving average 23.05
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:2
Last split Date 17 Jul 2006
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -0.04%
Operating margin -0.06%
Operational effectiveness
Return on assets -0.02%
Return on equity -0.03%
Income Statement
Revenue (ttm) 638.78M
Revenue per share (ttm) 4.98
Quarterly revenue growth (yoy) -0.03%
Gross profit (ttm) 445.11M
EBITDA -30.67M
Net income to common (ttm) -22.66M
Diluted EPS (ttm) -0.18
Quarterly earnings growth (yoy) -0.03%
Balance Sheet
Total cash (mrq) 539.85M
Total cash per share (mrq) 4.21
Total debt (mrq) 81.39M
Total Debt/Equity (mrq) 0.1
Current ratio (mrq) 5.9%
Book value per share (mrq) 6.35
Cash Flow
Cash flow statement 127.82M
Levered free cash flow (LFCF) 124.55M
